CAIE A-Level Biology A2 19.2.4 Genetic Medicine Considerations Questions

Use real exam evidence to balance diagnosis and treatment benefits against uncertainty, access and discrimination, then evaluate embryo selection and gene-therapy risks.

Syllabus
2028–2030
Course
Biology 9700
Level
A2

Exam points

  • Balance genetic-screening benefits such as preparation, early management and informed family choice against uncertainty, anxiety, discrimination, cost and unequal access.
  • Evaluate embryo screening through avoidance of serious disease, implantation or pregnancy outcomes, embryo damage or disposal, beliefs, reproductive choice and selection concerns.
  • Assess gene therapy through potential cure and quality-of-life gains against cost, limited evidence, immune or viral-vector risk, insertional mutation, side effects and uncertain duration.

CAIE A-Level Biology A2 19.2.4 Genetic Medicine Considerations Questions question 1

[Maximum number: 3]

Lung epithelial cells have a thin layer of watery mucus on their surface.
The normal allele of the CFTR gene codes for a transport protein that transports chloride ions out of epithelial cells.

Fig. 4.1 is a diagram of part of the cell surface membrane and the mucus layer of an epithelial cell with normal CFTR proteins.

Fig. 4.1

Fig. 4.1

Cystic fibrosis (CF) is a genetic disorder caused by having two recessive alleles of CFTR. In severe cases of CF, the transport proteins are not added to the cell surface membrane. This causes the mucus layer to be thick and sticky.

Embryos produced by IVF may be screened for genetic abnormalities:
- to test for a specific genetic disease, such as cystic fibrosis
- to check whether there is an abnormal number of chromosomes present.

To improve the success of implantation and pregnancy, only embryos without any form of genetic abnormality are transferred to the woman's uterus.

A new double screening method was trialled where a single embryo biopsy was taken and used to test for a specific genetic disease and to check the number of chromosomes. In the trial, 1122 embryos were tested using this double screening method.

In the trial, of the 1122 embryos tested:
- 50.6 % did not have a genetic disease
- 27.5 % did not have a genetic disease and did not have an abnormal number of chromosomes (normal embryos).

Only normal embryos were transferred into the women. The percentage of embryo transfers that resulted in pregnancy was calculated.

The results of the trial using double screening of a single biopsy were compared to the results of IVF procedures that used standard screening methods, as shown in Table 4.1.

Table 4.1

Table 4.1

Using the data in Table 4.1, discuss the social and ethical considerations of double screening for cystic fibrosis and chromosomal abnormalities in a single biopsy.

All question bank results loaded